Fragment-Based Drug Discovery

作者：Daniel A. Erlanson, Robert S. McDowell, Tom O'Brien · 发表于：Journal of Medicinal Chemistry · 年份：2004 · DOI：10.1021/jm040031v · 被引用次数：644 · 研究领域：Click Chemistry and Applications、Computational Drug Discovery Methods、Chemical Synthesis and Analysis

ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTFragment-Based Drug DiscoveryDaniel A. Erlanson, Robert S. McDowell, and Tom O'BrienView Author Information Sunesis Pharmaceuticals, Inc., 341 Oyster Point Boulevard, South San Francisco, California 94080 Cite this: J. Med. Chem. 2004, 47, 14, 3463–3482Publication Date (Web):June 4, 2004Publication History Received11 February 2004Published online4 June 2004Published inissue 1 July 2004https://doi.org/10.1021/jm040031vCopyright © 2004 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views12065Altmetric-Citations497LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFac...